Achmea Investment Management B.V. Has $1.87 Million Position in Bath & Body Works, Inc. (NYSE:BBWI)

Achmea Investment Management B.V. lowered its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 66.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 48,178 shares of the company's stock after selling 93,909 shares during the period. Achmea Investment Management B.V.'s holdings in Bath & Body Works were worth $1,868,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. SRS Capital Advisors Inc. boosted its holdings in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after buying an additional 329 shares during the last quarter. Golden State Wealth Management LLC bought a new position in Bath & Body Works during the fourth quarter worth about $26,000. UMB Bank n.a. boosted its holdings in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after buying an additional 335 shares during the last quarter. Lindbrook Capital LLC boosted its holdings in Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after buying an additional 431 shares during the last quarter. Finally, Smartleaf Asset Management LLC boosted its holdings in Bath & Body Works by 135.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock worth $39,000 after buying an additional 582 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Remove Ads

Bath & Body Works Trading Up 0.9 %

Shares of NYSE:BBWI traded up $0.26 during trading on Wednesday, hitting $30.24. 5,886,906 shares of the company were exchanged, compared to its average volume of 4,092,079. The stock has a market cap of $6.55 billion, a price-to-earnings ratio of 7.37, a P/E/G ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a fifty-two week low of $26.21 and a fifty-two week high of $52.99. The firm has a fifty day moving average price of $36.10 and a two-hundred day moving average price of $33.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.65%. The ex-dividend date was Friday, February 21st. Bath & Body Works's dividend payout ratio (DPR) is 21.98%.

Bath & Body Works declared that its board has authorized a stock buyback program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.4% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

BBWI has been the topic of a number of recent analyst reports. Raymond James restated an "outperform" rating and set a $46.00 target price (up previously from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. JPMorgan Chase & Co. set a $47.00 price objective on Bath & Body Works in a report on Thursday, February 27th. Deutsche Bank Aktiengesellschaft lifted their price objective on Bath & Body Works from $51.00 to $52.00 and gave the company a "buy" rating in a report on Tuesday, November 26th. Piper Sandler lifted their price objective on Bath & Body Works from $36.00 to $39.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Finally, Cowen reiterated a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works has an average rating of "Moderate Buy" and an average price target of $45.06.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.